Clinical Trial Update: Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment [Phase 1]

View source ↗

Summary

This is an early-phase (Phase 1) clinical trial evaluating the investigational drug 2141-V11 in patients with non-muscle invasive bladder cancer that did not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• 2141-V11

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non-muscle Invasive Bladder Cancer | Phase 1 | Status: RECRUITING